Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.12 +8.00%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
- Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance
- Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
